Evidence-based Practice II (1 Credit Hour)

Event Date : 07/03/2025 - 30/04/2025
Start 7 Mar 2025


The MiC in Evidence-based Practice II introduces basics of epidemiology and epidemiological study designs, pharmacovigilance and their application in healthcare practice. This module provides the knowledge and skills necessary to incorporate the best practices on the quality use of medications (safety, efficacy, acceptability, etc.) in the care of individual patients.

Learn more about IMU’s Master in Pharmacy Practice CLICK HERE

Mode of Delivery / Credit Hours

  • Synchronous = 31 (%)
    Asynchronous = 69 (%)
  • Credit Hours: 1

At the end of this course, the learners should be able to:

  1. Appraise epidemiology and pharmacoepidemiology studies
  2. Formulate clinical decisions using pharmacovigilance principles.

  • Introduction to epidemiology (Seminar 3 h)
    a. Definition, scope, and principle of epidemiology
    b. Drug approval process and post-marketing surveillance
    c. Epidemiology research
    d. Role of pharmacists
  • Study designs for epidemiology (Guided reading 2 h; seminar 3 h)
    a. Observational designs (case reports and series; cross-sectional, cohort, and case-control studies)
    b. Randomized controlled trials
    c. Systematic reviews and meta-analysis
    d. Reporting statements or guidelines for epidemiology and pharmacoepidemiology studies
    e. The strengths and limitations of each type of study design
  • Medication utilization pattern and evaluation (Guided Reading 2 h)
    a. Compliance, adherence, concordance, and persistence
    b. Patterns of suboptimal medication utilization
    c. Direct and indirect methods of measuring medication utilization
    d. Calculation of adherence/persistence and tools to assess compliance to medications
  • Medication safety and pharmacovigilance (Guided reading 3 h)
    a. Introduction, definition, and scope of pharmacovigilance
    b. The terminology of drug safety (Signals, side effects, adverse events, adverse drug reaction [ADR]
    c. Classification of ADR
    d. Monitoring drug safety
    e. International and national pharmacovigilance programmes
  • General principles of ADR reporting for health professionals (Seminar 2 h; demonstration 2 h)
    a. Hospital-based pharmacovigilance program in Malaysia; MADRAC
    b. Principles of ADR Reporting; Confidentiality
    c. Tools in ADR reporting in Malaysia
    d. Concept and importance of periodic safety update reports; risk communication
    e. Demonstration of ADR reporting in a hospital setting
  • Analysing an ADR (Workshop 3 h)
    A case scenario will be given for which students have to document the ADR in the reporting form and evaluate the same for various parameters (causality, severity, and preventability) including discussion on identification and prevention of ADR.

  • Medical Doctors
  • Pharmacists
  • Dentists
  • Nurses
  • Pharmaceutical scientists
  • Academics
  • Pharmacovigilance associates
  • Researchers of healthcare field
  • Any individual with healthcare background

  • Dr Palanisamy Sivanandy
    Programme Director, Master in Pharmacy Practice
    Dr Palanisamy Sivanandy is an eminent academician and researcher has more than 15 years of teaching and research experience. He has more than 22 years of experience in the pharmacy field and has won several national and international awards for his contributions to research and teaching. He coordinates the Management of Healthcare Institutions and Pharmacoeconomics modules. His main areas of research are patient safety, pharmacovigilance, social pharmacy, cancer research, metabolic disorders, health education, public health, social and policy research. He has won 13 international and national awards for his contributions to pharmacy teaching and research.
  • Dr Lo Yoke Lin
    Associate Professor
    Dr Lo Yoke Lin is a dedicated professional with many years of combined experience as a pharmacist, educator, and researcher in hospital and university environments. She has a strong commitment to the quality use of medicines and better health outcomes. She has won several awards in research and clinical pharmacy; as well as successfully secured national research grants. Her research interests include population pharmacokinetic-pharmacodynamic studies in the hospital setting, social pharmacy, epidemiology studies, and evidence-based practice.


General / Public RM1000
Students & Alumni RM800
Register now
Back to Event Details

Create an Account